2019
DOI: 10.1016/j.atherosclerosis.2018.12.004
|View full text |Cite
|
Sign up to set email alerts
|

Serum magnesium and the prevalence of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
8
1

Year Published

2019
2019
2021
2021

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 15 publications
(13 citation statements)
references
References 34 publications
0
8
1
Order By: Relevance
“…The absence of associations between magnesium intake and all markers of vascular structure and function in this cohort contradicts the more established association between dietary magnesium intake and CVD and mortality observed in systematic reviews and meta-analyses [ 3 7 ]. Similarly, these results are not in line with the mainly confirmative studies of serum magnesium concentrations in relation to vascular outcomes [ 16 20 , 56 , 57 ]. These inconsistencies could be explained in several ways.…”
Section: Discussioncontrasting
confidence: 62%
“…The absence of associations between magnesium intake and all markers of vascular structure and function in this cohort contradicts the more established association between dietary magnesium intake and CVD and mortality observed in systematic reviews and meta-analyses [ 3 7 ]. Similarly, these results are not in line with the mainly confirmative studies of serum magnesium concentrations in relation to vascular outcomes [ 16 20 , 56 , 57 ]. These inconsistencies could be explained in several ways.…”
Section: Discussioncontrasting
confidence: 62%
“…Later on, during the 1990s, different studies in patients showed that lower Mg plasma concentrations were associated with atherosclerosis [ 21 ], and that Mg supplementation lowered plasma cholesterol, LDL, and triglyceride concentrations [ 22 , 23 ]. Recent studies also found an inverse correlation between Mg levels, carotid intima–media thickness (cIMT) [ 24 , 25 ] and peripheral artery disease [ 26 , 27 ], while many epidemiological studies and clinical trials reported Mg as a key player in cardiovascular health [ 28 , 29 , 30 , 31 ], even in hemodialysis patients [ 32 ]. However, randomized clinical trials with Mg supplementation have yielded conflicting results [ 33 , 34 ].…”
Section: Introductionmentioning
confidence: 99%
“… 2–4 Our previous studies further demonstrated that new factors such as serum magnesium, cadmium and C reactive protein were associated with the incidence of lower-extremity PAD. 5 6 Hyperglycemia is a known risk factor for cardiovascular disease (CVD). However, less attention was paid to the role of normal blood glucose in the process of lower-extremity PAD.…”
Section: Introductionmentioning
confidence: 99%